Correction: Sun, Y.; et al. Design, Synthesis, and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors. Molecules 2017, 22, 1739.

The author wishes to make the following corrections to this paper [...].

The author wishes to make the following corrections to this paper [1]. Due to our oversight, the title of article [1] was same as that of article [2]. Because our research ideas and methods were different from those of article [2], we did not list it as a reference study in the article [1]. We would like to offer our sincere apologies to all of the authors of the article [2], who were Addla Dinesh, Jallapally Anvesh, Kanwal Abhinav, Sridhar Balasubramanian, Banerjee Sanjay K., and Kantevari Srinivas.

The corrections include: (1) replacing the title “Design, Synthesis, and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors” with “Design, Synthesis, and Evaluation of Novel Phenolic acid/Dipeptide/Borneol Hybrids as Potent Angiotensin Converting Enzyme (ACE) Inhibitors with Anti-hypertension Activity”; and (2) replacing “2-hydroxypyrrolobenzodiazepine-5,11-dione analogues” with “phenolic acid/dipeptide/borneol hybrids” in the abstract.

The authors would like to apologize for any inconvenience caused to the readers by these changes.